119 related articles for article (PubMed ID: 31617270)
1. Antibody response to vaccination after haematopoietic cell transplantation in children using a reduced dose schedule-A retrospective cohort study.
Jensen L; Poulsen A; Nygaard U; Scheike T; Riis MS; Pedersen FK; Heilmann C
Pediatr Transplant; 2020 Feb; 24(1):e13599. PubMed ID: 31617270
[TBL] [Abstract][Full Text] [Related]
2. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
[TBL] [Abstract][Full Text] [Related]
3. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
[TBL] [Abstract][Full Text] [Related]
6. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
7. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T; Voysey M; Yu LM; McCarthy N; Baudin M; Richard P; Fiquet A; Kitchin N; Pollard AJ
Vaccine; 2015 Aug; 33(36):4579-85. PubMed ID: 26165918
[TBL] [Abstract][Full Text] [Related]
9. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
[No Abstract] [Full Text] [Related]
10. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
[TBL] [Abstract][Full Text] [Related]
12. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine.
Tichmann-Schumann I; Soemantri P; Behre U; Disselhoff J; Mahler H; Maechler G; Sänger R; Jacquet JM; Schuerman L
Pediatr Infect Dis J; 2005 Jan; 24(1):70-7. PubMed ID: 15665713
[TBL] [Abstract][Full Text] [Related]
14. Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Gouveia-Alves F; Gouveia R; Ginani VC; Seber A; Kuramoto DA; Murad GFA; Spina FG; Petrilli AS; Zecchin VG; Granato C; Carlesse F; de Moraes-Pinto MI
Transpl Infect Dis; 2018 Aug; 20(4):e12903. PubMed ID: 29668078
[TBL] [Abstract][Full Text] [Related]
15. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
16. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
Rieckmann A; Hærskjold A; Benn CS; Aaby P; Lange T; Sørup S
Int J Epidemiol; 2019 Dec; 48(6):2026-2038. PubMed ID: 31062020
[TBL] [Abstract][Full Text] [Related]
17. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
18. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
[TBL] [Abstract][Full Text] [Related]
20. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
